1,551
Views
9
CrossRef citations to date
0
Altmetric
Preliminary Communication

Platelet Phosphorylated TDP-43: An Exploratory Study for a Peripheral Surrogate Biomarker Development for Alzheimer’s Disease

, , , &
Article: FSO238 | Received 13 Jul 2017, Accepted 28 Jul 2017, Published online: 16 Aug 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Emanuele Buratti. (2018) TDP-43 post-translational modifications in health and disease. Expert Opinion on Therapeutic Targets 22:3, pages 279-293.
Read now

Articles from other publishers (8)

A. N. Kodintsev, N. V. Izmozherova, A. A. Popov, L. I. Volkova, I. P. Antropova & A. V. Ryabinina. (2023) Biochemical Platelet Markers of Cognitive Impairments in Alzheimer’s Disease. Neurochemical Journal 17:1, pages 10-18.
Crossref
Heather M. Wilkins, Mazen M. Dimachkie & Abdulbaki Agbas. 2021. Amyotrophic Lateral Sclerosis. Amyotrophic Lateral Sclerosis 105 120 .
Zi‐Qi Huang, Zhi‐Sheng Ba, Nan‐Qu Huang, Yuan‐Yuan Li & Yong Luo. (2021) Aberrant TDP‐43 phosphorylation: a key wind gap from TDP‐43 to TDP‐43 proteinopathy. Ibrain 7:2, pages 119-131.
Crossref
Abdulbaki Agbas. 2019. Neurochemical Basis of Brain Function and Dysfunction. Neurochemical Basis of Brain Function and Dysfunction.
Petra Steinacker, Peggy Barschke & Markus Otto. (2019) Biomarkers for diseases with TDP-43 pathology. Molecular and Cellular Neuroscience 97, pages 43-59.
Crossref
Miki Hishizawa, Hirofumi Yamashita, Mayumi Akizuki, Makoto Urushitani & Ryosuke Takahashi. (2019) TDP-43 levels are higher in platelets from patients with sporadic amyotrophic lateral sclerosis than in healthy controls. Neurochemistry International 124, pages 41-45.
Crossref
Brati Das & Riqiang Yan. (2019) A Close Look at BACE1 Inhibitors for Alzheimer’s Disease Treatment. CNS Drugs 33:3, pages 251-263.
Crossref
Jeffrey M. Statland, Dan Moore, Yunxia Wang, Maureen Walsh, Tahseen Mozaffar, Lauren Elman, Sharon P. Nations, Hiroshi Mitsumoto, J. Americo Fernandes, David Saperstein, Ghazala Hayat, Laura Herbelin, Chafic Karam, Jonathan Katz, Heather M. Wilkins, Abdulbaki Agbas, Russell H. Swerdlow, Regina M. Santella, Mazen M. Dimachkie & Richard J. Barohn. (2018) Rasagiline for amyotrophic lateral sclerosis: A randomized, controlled trial. Muscle & Nerve 59:2, pages 201-207.
Crossref